Daniel S. Goldman sold Fabrinet (NYSE: FN)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Fabrinet (FN) since 2023, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $15,001 - $50,000 of Fabrinet (NYSE: FN) on July 12, 2023. Since that trade, FN is up +232.10% against the S&P 500 up +72.17%, an outperformance of +159.93%.
Data updated
Daniel S. Goldman's FN trades vs the price
FN is up +232.10% since Daniel S. Goldman sold on July 12, 2023, versus +72.17% for the S&P 500.
Performance since this trade
All Daniel S. Goldman FN trades
Daniel S. Goldman & FN trading FAQ
Is it legal for Daniel S. Goldman to trade Fabrinet (FN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Fabrinet (FN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell FN?
Daniel S. Goldman disclosed a sale of $15,001 - $50,000 of Fabrinet (FN) on July 12, 2023, according to public STOCK Act filings.
How has FN performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold FN on July 12, 2023, the stock is up +232.10%, versus +72.17% for the S&P 500 over the same period, an outperformance of +159.93%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional FN trades?
Quantellect tracks every disclosed congressional trade in Fabrinet (FN) on the Fabrinet congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's FN tradesAll congressional filings for FabrinetDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.